GSK is continuing to follow the patients in RUBY to see if overall survival data will support an all-comer label in future. A second stage of the study is also looking at adding GSK's PARP ...

which the company reckons could allow for an all-comer label without the ESR1 mutation restriction. AZ is also looking at adjuvant treatment with camizestrant in the CAMBRIA-1 and CAMBRIA-2 ...

One big plus about this monochrome laser printer is it not only supports connecting to a single computer but also has built-in wireless connectivity, so you can print your labels and stickers from ...

It says that at present it’s focused on “building global expansion strategies for K-pop labels.” Under the deal with Luminate, KreatorsNetwork will have an exclusive license to sell and distribute ...